Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03092011 · ClinicalTrials.gov registry record · Phase 4
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
A Phase 4 study of Neonatal Abstinence Syndrome, sponsored by The Cooper Health System.
- Active
- Registry status
- Phase 4
- Development phase
- 69
- Enrollment target
- 1
- Study location
NCT03092011: Active Phase 4 study of Neonatal Abstinence Syndrome, sponsored by The Cooper Health System.
NCT03092011 is a Phase 4 study of Neonatal Abstinence Syndrome that is active but no longer recruiting, run by The Cooper Health System. The registered enrollment target is 69 participants, above the 62-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (11% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03092011, a Phase 4 study of Neonatal Abstinence Syndrome, is active but no longer recruiting, sponsored by The Cooper Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 69 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to show non-inferiority between two medications used for medical treatment of withdrawal seen in Neonatal Abstinence Syndrome (NAS), Clonidine and Morphine Sulfate (used in routine care) on length of treatment for NAS .
Primary Outcome
Duration of treatment of Neonatal Abstinence Syndrome with medication/pharmacological treatment from first day initiated until medication has been stopped or patient discharged home
Conditions Studied
Interventions
- DRUG Morphine Sulfate
- DRUG Clonidine
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
What the registry record for NCT03092011 still lists
NCT03092011 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, above the 62-participant average among 17 other Neonatal Abstinence Syndrome trials with a reported enrollment target (11% higher).
The record links to 1 condition, with Neonatal Abstinence Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Morphine Sulfate is the first listed.
NCT03092011 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT03092011 about?
NCT03092011 is a clinical study titled "Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy". The purpose of this study is to show non-inferiority between two medications used for medical treatment of withdrawal seen in Neonatal Abstinence Syndrome (NAS), Clonidine and Morphine Sulfate (used in routine care) on length of treatment for NAS .
What is the current status of trial NCT03092011?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 69 participants. The study started on 2018-02-21. Estimated completion is 2026-12-01.
What conditions does trial NCT03092011 study?
This clinical trial studies the following conditions: Neonatal Abstinence Syndrome.
What interventions are being tested in trial NCT03092011?
The interventions under investigation include: Morphine Sulfate (DRUG), Clonidine (DRUG).
Who is sponsoring clinical trial NCT03092011?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03092011 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Abstinence Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03092011's enrollment target sits among peer trials
69 8th of 17 higher than 10 of 17 other Neonatal Abstinence Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Neonatal Abstinence Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatment of Neonatal Abstinence Syndrome
COMPLETED · Phase 4
-
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
COMPLETED · Phase 4
-
An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)
RECRUITING · NA
-
MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
RECRUITING
-
A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants
ACTIVE NOT RECRUITING · NA
-
Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI